Koninklijke Philips N.V. (NYSE:PHG) Stock Now Rated “Hold” by Sell-Side Analysts

Koninklijke Philips N.V. (NYSE:PHG) has earned a consensus recommendation of “Hold” from the five analysts that are covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating.

Several research analysts have commented on PHG shares. Weiss Ratings downgraded shares of Koninklijke Philips from a “hold (c+)” rating to a “hold (c)” rating in a research note on Tuesday, October 6th. UBS Group reaffirmed a “neutral” rating on shares of Koninklijke Philips in a research note on Monday, August 3rd. Finally, Zacks Research raised shares of Koninklijke Philips from a “strong sell” rating to a “hold” rating in a report on Thursday, August 13th.

Koninklijke Philips Price Performance

Shares of NYSE PHG traded up $0.26 during trading hours on Friday, reaching $25.75. 1,338,634 shares of the stock traded hands, compared to its average volume of 1,151,310. The company’s 50-day simple moving average is $25.62 and its two-hundred day simple moving average is $26.46. The company has a market capitalization of $25.30 billion, a P/E ratio of 18.97, a price-to-earnings-growth ratio of 10.59 and a beta of 0.77. Koninklijke Philips has a 52-week low of $23.62 and a 52-week high of $33.44. The company has a quick ratio of 0.82, a current ratio of 1.26 and a debt-to-equity ratio of 0.55.

Koninklijke Philips (NYSE:PHG) last issued its earnings results on Monday, July 27th. The technology company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.17. Koninklijke Philips had a return on equity of 14.38% and a net margin of 6.30%. The business had revenue of $4.98 billion during the quarter, compared to analyst estimates of $4.91 billion. During the same quarter in the prior year, the firm earned $0.27 earnings per share. Koninklijke Philips’s revenue for the quarter was down 3.0% on a year-over-year basis. Equities research analysts forecast that Koninklijke Philips will post 1.74 EPS for the current year.

Institutional Trading of Koninklijke Philips

Several hedge funds have recently added to or reduced their stakes in PHG. Bank of America Corp DE boosted its position in Koninklijke Philips by 7.7% during the first quarter. Bank of America Corp DE now owns 700,141 shares of the technology company’s stock valued at $19,184,000 after buying an additional 50,124 shares during the period. Investment Management Associates Inc. ADV increased its holdings in shares of Koninklijke Philips by 1.5% in the first quarter. Investment Management Associates Inc. ADV now owns 515,007 shares of the technology company’s stock worth $14,111,000 after buying an additional 7,743 shares during the period. Royal Bank of Canada increased its holdings in shares of Koninklijke Philips by 13.1% in the first quarter. Royal Bank of Canada now owns 495,310 shares of the technology company’s stock worth $13,572,000 after buying an additional 57,514 shares during the period. Sei Investments Co. lifted its stake in shares of Koninklijke Philips by 4.7% in the 1st quarter. Sei Investments Co. now owns 486,941 shares of the technology company’s stock valued at $13,343,000 after acquiring an additional 22,039 shares during the last quarter. Finally, Tidal Investments LLC lifted its stake in shares of Koninklijke Philips by 18.9% in the 2nd quarter. Tidal Investments LLC now owns 401,637 shares of the technology company’s stock valued at $10,921,000 after acquiring an additional 63,868 shares during the last quarter. 13.67% of the stock is owned by institutional investors.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. is a Netherlands-based health technology company that develops products, services and software for healthcare providers, health systems and consumers. The company focuses on improving diagnosis, treatment and health management through connected technologies and data-enabled solutions.

Philips’ healthcare portfolio includes diagnostic imaging systems such as magnetic resonance imaging, computed tomography and ultrasound equipment; image-guided therapy systems; patient monitoring and clinical informatics technologies; and solutions for sleep and respiratory care.